共 50 条
Guillain-Barre syndrome: background incidence rates in The Netherlands
被引:14
|作者:
van der Maas, Nicoline A. T.
[1
,2
,3
]
Kramer, Merlijn A.
[1
]
Jacobs, Bart C.
[2
,3
]
van Soest, Eva M.
[4
]
Dieleman, Jeanne P.
[4
]
Kemmeren, Jeanet M.
[1
]
de Melker, Hester E.
[1
]
Sturkenboom, Miriam C. J. M.
[5
]
机构:
[1] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands
[2] Univ Med Ctr, Dept Neurol, Rotterdam, Netherlands
[3] Univ Med Ctr, Dept Immunol, Rotterdam, Netherlands
[4] Univ Med Ctr, Dept Med Informat, Rotterdam, Netherlands
[5] Univ Med Ctr, Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands
关键词:
Guillain-Barre syndrome;
incidence rate;
vaccination;
PATIENT RECORDS;
IMMUNIZATION;
SURVEILLANCE;
FEATURES;
D O I:
10.1111/j.1529-8027.2011.00356.x
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
Guillain-Barre syndrome (GBS) is a (sub) acute polyradiculoneuropathy, which may occur following immunization. To interpret the occurrence of GBS after introduction of large-scale immunization programmes, it is important to define recent background incidence rates (IRs) of GBS. We used a general practitioner electronic medical record database to assess age-specific GBS IRs between 1996 and 2008 in The Netherlands. All possible GBS cases were manually reviewed. Validated incident cases were reviewed by a neurologist (B. J.) for diagnostic certainty using the GBS case definition of the Brighton Collaboration (BC). In a population of 638,891 persons, we identified 23 validated incident GBS cases (mean age 46 years). IR was 1.14 per 100,000 person years (95% confidence interval [CI] 0.67-1.61) and was lower for people under 50 years (0.76; 95% CI 0.41-1.32) compared with elderly of 50 years or older (1.80; 95% CI 0.98-3.05). Only six cases fulfilled level 1 or 2 of diagnostic certainty of the BC case definition. IR of GBS increases with age. As vaccinations are often targeted at specific age groups, age-specific rates should be used to monitor GBS observed versus expected rates after introduction of large-scale vaccination programmes.
引用
收藏
页码:243 / 249
页数:7
相关论文